Press Releases Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
19.06 ^USD	-2.36%		+0.26%	+8.67%

May. 14	Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM
Apr. 23	Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kiniksa Pharmaceuticals : Investor Presentation	Jun. 06	PU
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference	Jun. 04	AQ
Sector Spotlight: Orphan Drug Developers With Significant Upside	Jun. 03	AQ
Analysts Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL)	May. 28	AQ
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference	May. 07	AQ
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution	Apr. 23	AQ
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024	Apr. 16	AQ
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	Apr. 02	AQ
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K	Mar. 29	PU
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution	Feb. 28	AQ
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024	Feb. 21	AQ
Kiniksa Pharmaceuticals Provides Corporate Update	Jan. 04	AQ
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	AQ
Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution	23-10-31	AQ
Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023	23-10-24	AQ
Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution	23-07-25	AQ
Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023	23-07-17	AQ
Kiniksa Pharmaceuticals : 2022 Annual Report	23-06-14	PU
Kiniksa Pharmaceuticals : 2023 Proxy Statement	23-06-14	PU
Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference	23-06-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Press Releases

Filters